mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.3 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.3 |